(Q88975322)
Statements
Screening of FDA-approved drugs using a MERS-CoV clinical isolate from South Korea identifies potential therapeutic options for COVID-19 (English)
0 references
Meehyun Ko
0 references
So Young Chang
0 references
Soo Young Byun
0 references
Inhee Choi
0 references
Anne-Laure Pham Hung d’Alexandry d’Orengiani
0 references
David Shum
0 references
Ji-Young Min
0 references
Marc P. Windisch
0 references
2 March 2020
0 references